# Phase 12 — Implementation Foundation / Project Initialization — Part 1

**Status:** Phase 12 APPROVED. Phases 04–12 APPROVED; Phase 13 Part 1 APPROVED; Phase 13 Part 2 AUTHORIZED / IN PROGRESS.

**HISTORICAL SNAPSHOT — NOT CURRENT PROJECT STATUS**

The report below preserves the Phase 12 delivery evidence and original approval recommendations; its former next-phase status does not override current authorization above.

## Deliverables

Created a runnable, provider-neutral monorepo foundation for NexusAI:

- Root pnpm workspace, strict TypeScript, ESLint, Prettier, Vitest, editor settings, `.gitignore`, and names-only `.env.example`.
- `apps/web`: Next.js/React shell.
- `apps/api`: Fastify composition with `/health/live`, `/health/ready`, `/api/v1`, and `/internal/v1` foundation routes.
- `apps/worker`: background-job process boundary with approved job categories.
- Shared packages for config, contracts, domain IDs/ownership, policy/safety, auth boundary, AI gateway, and observability.
- Database boundary README referencing the approved 21-entity design without creating schema or migrations.
- Representative tests for safety modes and API prefix contracts.

## Validation performed

- Workspace dependency installation completed with `pnpm install --ignore-scripts`.
- All workspace packages and the web application built successfully.
- API, worker, and web TypeScript no-emit checks passed.
- Foundation Vitest suite passed (2 tests).
- ESLint and scoped Prettier checks were run against implementation/config files; generated artifacts and canonical documentation are excluded from formatting changes.
- Static review confirms the approved 21 database entities and 77 planned API operations are not altered; no active Operations Copilot requirements or excluded MVP features were introduced.

## Safety and privacy confirmation

No secrets, raw passwords, raw session tokens, raw provider payloads, or unnecessary medical fields were added. AI remains behind `ModelGateway`; memory is consent-gated and revocable; safety modes are explicit; ownership and internal-route boundaries are represented for later enforcement.

## Known limitations and blockers

This is scaffolding, not a usable health product. There are no business endpoints, persistence, authentication provider, model provider, notification delivery, or production deployment. All unresolved Phase 10/11 decisions remain TBD/PENDING and must be resolved through the documented phase gates before release.

## Approval gate

- [x] Part 1 foundation structure and tooling created.
- [x] Canonical architecture boundaries preserved.
- [x] Build, typecheck, lint/test validation executed.
- [x] No production application implementation started.
- [x] User approval to begin Phase 12 Part 2 was received.

**Next action:** Part 2 has its own report and gate. Full feature implementation, deployment, and public beta remain unauthorized until separately approved.
